Skip to main content
. 2016 Mar 10;48(5):1877–1885. doi: 10.3892/ijo.2016.3437

Figure 5.

Figure 5

miR-148a inhibited GC cells in vivo. Volumes of BGC-823 tumors in vivo were detected every three days with or without miR-148a transfection (n=6, two of each group are representative tumors of six) (A). Cell proliferation of BGC-823-miR-148a/BGC-823-vector in tumor tissue was determined with APC-Ki67 mAb using flow cytometry (B). Percentage of Ki67 in GC tissue from GC mouse model (n=6) (C). Expression of TGFβ2 and SMAD2 in GC cells with BGC-823-miR-148a/BGC-823-vector from tumor tissue (D).